CHCYX | PMBJX | CHCYX / PMBJX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 24 years | - |
Gain YTD | -2.249 | 1.887 | -119% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.62B | 29.6B | 9% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 7.86 | 12.32 | 64% |
Returns for 3 years | 10.88 | 27.43 | 40% |
Returns for 5 years | 4.07 | 34.04 | 12% |
Returns for 10 years | 32.17 | 88.55 | 36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLCX | 12.90 | -0.07 | -0.54% |
PGIM Jennison Health Sciences C | |||
QIORX | 15.10 | -0.21 | -1.37% |
AQR International Momentum Style R6 | |||
SLCVX | 26.55 | -0.38 | -1.41% |
Saratoga Large Capitalization Value I | |||
TIIRX | 26.96 | -0.56 | -2.03% |
Nuveen Core Equity A | |||
BPSIX | 26.20 | -0.57 | -2.13% |
Boston Partners Small Cap Value II I |